The concept of describing and guiding a patient‘s dental journey as determined by the causes, chronology and psycho-social sequelae of teeth loss, provides the context for the morning’s introductory session. Scientifically validated osseointegrated dental implant therapy has already dramatically improved the management of partial and complete edentulism. It now underscores the profession‘s eclectic and versatile role in the management of oral disease sequelae and the continuing emphasis on both patient and dentist mediated concerns in selecting best available treatment options.
Over three decades of clinical and biomaterials scientific innovations have already added new and exciting dimensions to osseointegration’s application. However, numerous concerns continue to challenge the notion of a universal therapeutic application of implant therapy. They include systemic interactions with the oral cavity and effects on osseointegration, an expanded understanding of the induced interface that results in osseointegration, as well as the ongoing need for even better evidence supporting long-term treatment outcome results and maintenance protocols.
The aim of this session is to reiterate and reinforce those key synergies that continue to enrich patients’ lives -between basic and laboratory sciences and their clinical application, and between industry and the profession.
- An increased understanding of background considerations in the identification of patient treatment selection.
- An update on current views regarding implant surface characteristics that influence bone and soft tissue responses.
- An appreciation for the methodologies used to evaluate the efficacy of long-term treatment outcomes
George Zarb, William Becker
Ann Wennerberg, Burton Langer, Gerard Chiche, Michael MacEntee, Patrick Henry, Philippe Hujoe, Peter Schüpbach